These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 30015720)
1. ALK Is a Specific Diagnostic Marker for Inflammatory Myofibroblastic Tumor of the Uterus. Mohammad N; Haimes JD; Mishkin S; Kudlow BA; Leong MY; Chew SH; Koay E; Whitehouse A; Cope N; Ali RH; Köbel M; Stewart CJR; McCluggage WG; Lee CH Am J Surg Pathol; 2018 Oct; 42(10):1353-1359. PubMed ID: 30015720 [TBL] [Abstract][Full Text] [Related]
2. Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1. Haimes JD; Stewart CJR; Kudlow BA; Culver BP; Meng B; Koay E; Whitehouse A; Cope N; Lee JC; Ng T; McCluggage WG; Lee CH Am J Surg Pathol; 2017 Jun; 41(6):773-780. PubMed ID: 28490045 [TBL] [Abstract][Full Text] [Related]
3. Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion. Cheek EH; Fadra N; Jackson RA; Davila JI; Sukov WR; Uckerman MT; Clayton A; Keeney GL; Halling KC; Torres-Mora J; Schoolmeester JK Hum Pathol; 2020 Mar; 97():29-39. PubMed ID: 31917155 [TBL] [Abstract][Full Text] [Related]
4. Pregnancy-associated Inflammatory Myofibroblastic Tumors of the Uterus Are Clinically Distinct and Highly Enriched for TIMP3-ALK and THBS1-ALK Fusions. Devereaux KA; Fitzpatrick MB; Hartinger S; Jones C; Kunder CA; Longacre TA Am J Surg Pathol; 2020 Jul; 44(7):970-981. PubMed ID: 32271187 [TBL] [Abstract][Full Text] [Related]
5. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors. Rabban JT; Zaloudek CJ; Shekitka KM; Tavassoli FA Am J Surg Pathol; 2005 Oct; 29(10):1348-55. PubMed ID: 16160478 [TBL] [Abstract][Full Text] [Related]
7. Uterine Inflammatory Myofibroblastic Tumor Showing an Atypical ALK Signal Pattern by FISH and DES-ALK Fusion by RNA Sequencing: A Case Report. Zarei S; Abdul-Karim FW; Chase DM; Astbury C; Policarpio-Nicolas MLC Int J Gynecol Pathol; 2020 Mar; 39(2):152-156. PubMed ID: 30741845 [TBL] [Abstract][Full Text] [Related]
8. ALK-rearranged Tumors Are Highly Enriched in the STUMP Subcategory of Uterine Tumors. Devereaux KA; Kunder CA; Longacre TA Am J Surg Pathol; 2019 Jan; 43(1):64-74. PubMed ID: 29794871 [TBL] [Abstract][Full Text] [Related]
9. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases. Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797 [TBL] [Abstract][Full Text] [Related]
10. STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion. Subbiah V; McMahon C; Patel S; Zinner R; Silva EG; Elvin JA; Subbiah IM; Ohaji C; Ganeshan DM; Anand D; Levenback CF; Berry J; Brennan T; Chmielecki J; Chalmers ZR; Mayfield J; Miller VA; Stephens PJ; Ross JS; Ali SM J Hematol Oncol; 2015 Jun; 8():66. PubMed ID: 26062823 [TBL] [Abstract][Full Text] [Related]
11. ALK Immunoexpression is Specific for Inflammatory Myofibroblastic Tumor Among Vulvovaginal Mesenchymal Neoplasms. Bowman CJ; Medeiros F; Fadare O; Sangoi AR; Horvai AE; Devine WP; McCluggage WG; Rabban JT Int J Gynecol Pathol; 2023 Jan; 42(1):1-10. PubMed ID: 35180768 [TBL] [Abstract][Full Text] [Related]
12. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases. Li XQ; Hisaoka M; Shi DR; Zhu XZ; Hashimoto H Hum Pathol; 2004 Jun; 35(6):711-21. PubMed ID: 15188137 [TBL] [Abstract][Full Text] [Related]
13. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report. Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760 [TBL] [Abstract][Full Text] [Related]
14. Uterine inflammatory myofibroblastic tumor: First report of a ROS1 fusion. Bennett JA; Wang P; Wanjari P; Diaz L; Oliva E Genes Chromosomes Cancer; 2021 Dec; 60(12):822-826. PubMed ID: 34322931 [TBL] [Abstract][Full Text] [Related]
15. Inflammatory Myofibroblastic Tumor of the Uterus: An Immunohistochemical Study of 23 Cases. Bennett JA; Croce S; Pesci A; Niu N; Van de Vijver K; Burks EJ; Burandt E; Zannoni GF; Rabban JT; Oliva E Am J Surg Pathol; 2020 Nov; 44(11):1441-1449. PubMed ID: 32568825 [TBL] [Abstract][Full Text] [Related]
16. Uterine inflammatory myofibroblastic tumor harboring novel NUDCD3-ROS1 and NRP2-ALK fusions: clinicopathologic features of 4 cases and literature review. Zhang L; Luan L; Shen L; Xue R; Huang J; Su J; Huang Y; Xu Y; Wang X; Shao Y; Ji Y; Xu C; Hou Y Virchows Arch; 2023 Mar; 482(3):567-580. PubMed ID: 36624188 [TBL] [Abstract][Full Text] [Related]
17. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297 [TBL] [Abstract][Full Text] [Related]
18. Histopathologic and Molecular Characterization of Uterine Leiomyoma-like Inflammatory Myofibroblastic Tumor: Comparison to Molecular Subtypes of Uterine Leiomyoma. Kuisma H; Jokinen V; Pasanen A; Heikinheimo O; Karhu A; Välimäki N; Aaltonen L; Bützow R Am J Surg Pathol; 2022 Aug; 46(8):1126-1136. PubMed ID: 35426837 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory myofibroblastic tumor of the uterus - case report. Štiková Z; Ptáková N; Horáková M; Kosťun J; Ondič O Cesk Patol; 2019; 55(4):239-243. PubMed ID: 31842556 [TBL] [Abstract][Full Text] [Related]
20. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Cook JR; Dehner LP; Collins MH; Ma Z; Morris SW; Coffin CM; Hill DA Am J Surg Pathol; 2001 Nov; 25(11):1364-71. PubMed ID: 11684952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]